In vitro and in vivo release of estradiol from an intra-muscular microsphere formulation

International Journal of Pharmaceutics

Volumn 148, Issue 1, 1997, Pages 55-61

  Dickinson, Paul A ^a   Kellaway, Ian W ^a   Taylor, Glyn ^a   Mohr, Detlef ^b   Nagels, Klaüs ^b   Wolff, Hans Michael ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Schwarz Pharma AG   (Germany)

Author keywords

17B estradiol; Biodegradable microspheres; Controlled release; In vitro; In vivo; Intra muscular; Poly(lactide co glycolide)

Indexed keywords

ESTRADIOL; MICROSPHERE; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG CLEARANCE; DRUG FORMULATION; DRUG RELEASE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RABBIT;

EID: 0030944553     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04823-5     Document Type: Article

References (12)

1. Aoki, S., Uesugi, K., Ozawa, H. and Kayano, M., Evaluation of the correlation between in vivo and in vitro release of phenylpropanolamine HC1 from controlled-release tablets. Int. J. Pharm., 85 (1992) 65-73.
2. Bonny, J.-D. and Kyowa, M., Use of in vitro release tests for the prediction of the in vivo behavior and the development of flucytosine controlled-release capsules. J. Pharm. Sci., 84 (1995) 619-623.
3. Bourget, C., Flood, C. and Longcope, C., Steroid dynamics in the rabbit. Steroids, 43 (1984) 225-233.
4. Fraser, I.S., Challis, J.R.G. and Thorburn, G.D., Metabolic clearance rate and production rate of oestradiol in conscious rabbits. J. Endocrinol., 68 (1976) 313-320.
5. Hermens, W.A.J.J., Deurloo, M.J.M., Romeyn, S.G., Verhoef, J.C. and Merkus, F.W.H.M., Nasal absorption Enhancement of 17β-estradiol by dimethyl-β-cyclodextrin in rabbits and rats. Pharm. Res., 7 (1990) 500-503.
6. Lagenbucher, F. and Mysicka, J., In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations. Brit. J. Clin. Pharmacol., 19 (1985) 151S-162S.
7. Lee, M.Y., Clark, J.E. and Williams, D.E., Induction of flavin-containing monooxygenase (FMO B) in rabbit lung and kidney by sex steroids and glucocorticoids. Arch. Biochem. Biophys., 302 (1993) 332-336.
8. Murthy, K.S. and Ghebre-Sellassie, I., Current perspectives on the dissolution stability of solid oral dosage forms. J. Pharm. Sci., 82 (1993) 113-126.
9. Patel, J., Katovich, M.J., Sloan, K.B., Curry, S.H. and Prankerd, R.J., A prodrug approach to increasing the oral potency of a phenolic drug. Part 2. Pharmacodynamics and preliminary bioavailability of an orally administered 0-(imidomethyl) derivative of 17β-estradiol. J. Pharm. Sci., 84 (1995) 174-178.
10. Skelley, J.P., Amidon, G.L., Barr, W.H., Benet, L.Z., Carter, J.E., Robinson, J.R., Shah, V.P. and Yacobi, A., Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms. J. Pharm. Sci., 79 (1990) 849-854 or Pharm. Res., 1 (1990) 975-982.
11. Skelley, J.P., Amidon, G.L., Barr, W.H., Benet, L.Z., Carter, J.E., Robinson, J.R., Shah, V.P. and Yacobi, A., Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms. J. Pharm. Sci., 79 (1990) 849-854 or Pharm. Res., 1 (1990) 975-982.
12. Tremblay, R.R., Braithwaite, S., Ho-Kim, M.A. and Dubé, J.Y., Effect of thyroid state on estradiol-17β metabolism in rabbits. Steroids, 29 (1977) 649-656.